VV

Vineet Vamanrao Joshi

Active Director Additional Director DIN 11703671
DIN 11703671 First appointment Aug 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vineet Vamanrao Joshi

Data last updated:

Vineet Vamanrao Joshi is an Additional Director at Akums Healthcare Limited (since 2026). The company operates in Pharma.

DIN 11703671
Primary Designation Additional Director
Industry Pharma
First Appointment 07 Aug 2026
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akums Healthcare Limited U24304DL2020PLC375098
Additional Director07 Aug 20262020Active

Board colleagues of Vineet Vamanrao Joshi

Directorship timeline

Open interactive timeline →
Akums Healthcare Limited
Premium access

Shareholding and investment profile for Vineet Vamanrao Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vineet Vamanrao Joshi

Vineet Vamanrao Joshi currently holds 1 directorship: Akums Healthcare Limited (Additional Director, since 07 Aug 2026).

Vineet Vamanrao Joshi was first appointed on 07 Aug 2026 as Additional Director at Akums Healthcare Limited.

The current boards of Vineet Vamanrao Joshi's companies include Basant Kumar Singh (Akums Healthcare Limited), Dilip Kumar Gupta (Akums Healthcare Limited), Lajpat Singh (Akums Healthcare Limited), Samandar Singh Dhakad (Akums Healthcare Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available